Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases

Introduction Patients with metastatic renal cell carcinoma have a poor prognosis and its specific pathogenesis remains unelucidated. Case presentation At 78 years of age, a Japanese male patient was diagnosed with metastatic renal cell carcinoma (cT3N2M1 stage) and multiple brain metastases that wer...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Daisuke Matsumoto, Taku Naiki, Aya Naiki‐Ito, Maria Aoki, Shinji Kato, Toshiharu Morikawa, Nobuhiko Shimizu, Masakazu Gonda, Yukihiro Umemoto, Takahiro Yasui
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-01-01
Edice:	IJU Case Reports
Témata:	brain neoplasms lenvatinib pembrolizumab radiosurgery renal cell carcinoma
On-line přístup:	https://doi.org/10.1002/iju5.12786
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!